MoneyWorks4Me

Sotac Pharmaceutical - Quaterly Results

05 Feb 2024 Evaluate
The sales surged to Rs. 176.81 millions, up 25.78% for the December 2023 quarter as against Rs. 140.57 millions during the corresponding quarter previous year.Net Profit witnessed a 192.75% growth almost the double from Rs. 5.10 millions to Rs. 14.93  millions  of same quarter last year.Operating Profit saw a handsome growth to 32.03 millions from 11.02 millions in the quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 176.81 140.57 25.78 365.91 291.04 25.72 579.83 731.52 -20.74
Other Income 2.71 0.05 5320.00 5.02 0.73 587.67 2.43 2.08 16.83
PBIDT 32.03 11.02 190.65 56.94 40.97 38.98 84.52 63.63 32.83
Interest 2.29 1.33 72.18 5.71 3.05 87.21 8.61 5.50 56.55
PBDT 27.42 9.69 182.97 48.91 37.92 28.98 75.91 58.13 30.59
Depreciation 6.83 4.32 58.10 11.46 7.68 49.22 16.25 11.26 44.32
PBT 20.59 5.37 283.43 37.45 30.24 23.84 59.66 46.87 27.29
TAX 5.66 0.27 1996.30 10.47 6.57 59.36 14.69 13.91 5.61
Deferred Tax 0.02 -0.37 -105.41 0.27 -1.08 -125.00 -2.15 -0.33 551.52
PAT 14.93 5.10 192.75 26.98 23.67 13.98 44.97 32.96 36.44
Equity 110.50 80.50 37.27 110.50 80.50 37.27 80.50 23.00 250.00
PBIDTM(%) 18.12 7.84 131.08 15.56 14.08 10.54 14.58 8.70 67.58
Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..